Surfactant

Exogenous pulmonary surfactant, widely used in neonatal care, is one of the best-studied treatments in neonatology, and its introduction in the 1990s led to a significant improvement in neonatal outcomes in preterm infants, including a decrease in mortality. This chapter provides an overview of surf...

Descripción completa

Detalles Bibliográficos
Autores principales: Soll, Roger F., Suresh, Gautham, Willson, Douglas, Egan, Edmund F., Notter, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175631/
http://dx.doi.org/10.1007/978-3-642-01219-8_28
_version_ 1783524870025379840
author Soll, Roger F.
Suresh, Gautham
Willson, Douglas
Egan, Edmund F.
Notter, Robert
author_facet Soll, Roger F.
Suresh, Gautham
Willson, Douglas
Egan, Edmund F.
Notter, Robert
author_sort Soll, Roger F.
collection PubMed
description Exogenous pulmonary surfactant, widely used in neonatal care, is one of the best-studied treatments in neonatology, and its introduction in the 1990s led to a significant improvement in neonatal outcomes in preterm infants, including a decrease in mortality. This chapter provides an overview of surfactant composition and function in health and disease and summarizes the evidence for its clinical use.
format Online
Article
Text
id pubmed-7175631
institution National Center for Biotechnology Information
language English
publishDate 2013
record_format MEDLINE/PubMed
spelling pubmed-71756312020-04-22 Surfactant Soll, Roger F. Suresh, Gautham Willson, Douglas Egan, Edmund F. Notter, Robert Pediatric and Neonatal Mechanical Ventilation Article Exogenous pulmonary surfactant, widely used in neonatal care, is one of the best-studied treatments in neonatology, and its introduction in the 1990s led to a significant improvement in neonatal outcomes in preterm infants, including a decrease in mortality. This chapter provides an overview of surfactant composition and function in health and disease and summarizes the evidence for its clinical use. 2013-10-08 /pmc/articles/PMC7175631/ http://dx.doi.org/10.1007/978-3-642-01219-8_28 Text en © Springer-Verlag Berlin Heidelberg 2015 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Soll, Roger F.
Suresh, Gautham
Willson, Douglas
Egan, Edmund F.
Notter, Robert
Surfactant
title Surfactant
title_full Surfactant
title_fullStr Surfactant
title_full_unstemmed Surfactant
title_short Surfactant
title_sort surfactant
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175631/
http://dx.doi.org/10.1007/978-3-642-01219-8_28
work_keys_str_mv AT sollrogerf surfactant
AT sureshgautham surfactant
AT willsondouglas surfactant
AT eganedmundf surfactant
AT notterrobert surfactant

Ejemplares similares